These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26931794)

  • 41. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
    Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
    BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Research Progress of Olfactory Event-related Potential and Its Forensic Application].
    Sun J; Fan LH; Liu X; Chen F
    Fa Yi Xue Za Zhi; 2017 Oct; 33(5):532-535. PubMed ID: 29275562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.
    Xie R; Xia B; Zhang X; Hu W; Zhao R; Xie C; Wang J; Zhang N; Wu S
    Oncotarget; 2016 Dec; 7(49):81918-81925. PubMed ID: 27636993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Olfactory function in patients with nasopharyngeal carcinoma following radiotherapy.
    Hua MS; Chen ST; Tang LM; Leung WM
    Brain Inj; 1999 Nov; 13(11):905-15. PubMed ID: 10579662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.
    Du CR; Ying HM; Kong FF; Zhai RP; Hu CS
    Radiat Oncol; 2015 Mar; 10():70. PubMed ID: 25889937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients.
    Nakahara S; Hanamoto A; Seo Y; Miyaguchi S; Yamamoto Y; Tomiyama Y; Yoshii T; Takenaka Y; Yoshioka Y; Isohashi F; Ogawa K; Inohara H
    Jpn J Clin Oncol; 2016 Oct; 46(10):903-910. PubMed ID: 27474126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.
    Su Z; Mao YP; Tang J; Lan XW; OuYang PY; Xie FY
    Tumour Biol; 2016 Apr; 37(4):4429-38. PubMed ID: 26499947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TPF induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: Long term results of a Tunisian series.
    Toumi N; Ben Kridis W; Mnejja W; Bouzguenda R; Khanfir A; Ghorbel A; Daoud J; Frikha M
    Cancer Radiother; 2018 May; 22(3):216-221. PubMed ID: 29650387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Zhang LN; Gao YH; Lan XW; Tang J; Su Z; Ma J; Deng W; OuYang PY; Xie FY
    Oncotarget; 2015 Dec; 6(41):44019-29. PubMed ID: 26528755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
    Li Y; Chen QY; Tang LQ; Liu LT; Guo SS; Guo L; Mo HY; Chen MY; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Shao JY; Sun Y; Tan J; Chen S; Ma J; Zhao C; Mai HQ
    BMC Cancer; 2017 Aug; 17(1):567. PubMed ID: 28836950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
    Satake H; Tahara M; Mochizuki S; Kato K; Hara H; Yokota T; Kiyota N; Kii T; Chin K; Zenda S; Kojima T; Bando H; Yamazaki T; Iwasa S; Honma Y; Hamauchi S; Tsushima T; Ohtsu A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):91-9. PubMed ID: 27193097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Zheng J; Wang G; Yang GY; Wang D; Luo X; Chen C; Zhang Z; Li Q; Xu W; Li Z; Wang D
    Jpn J Clin Oncol; 2010 May; 40(5):425-31. PubMed ID: 20085903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.
    Gao Y; Huang HQ; Bai B; Cai QC; Wang XX; Cai QQ
    Expert Opin Pharmacother; 2014 Feb; 15(2):163-71. PubMed ID: 24295173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olfactory and intranasal trigeminal event-related potentials in anosmic patients.
    Kobal G; Hummel T
    Laryngoscope; 1998 Jul; 108(7):1033-5. PubMed ID: 9665252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Olfactory testing in clinical practice.
    Rombaux P; Collet S; Martinage S; Eloy P; Bertrand B; Negoias S; Hummel T
    B-ENT; 2009; 5 Suppl 13():39-51. PubMed ID: 20084804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensorineural hearing loss following induction chemotherapy plus concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma.
    Atchariyasathian V; Pruegsanusak K; Wongsriwattanakul S
    J Laryngol Otol; 2015 Aug; 129(8):767-72. PubMed ID: 26112091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical examination of olfactory and gustatory function].
    Yang L; Wei Y; Zhang W; Ren Y; Yu D; Li K; Guo Y; Zhang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jul; 26(14):625-8. PubMed ID: 23156803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines Survival.
    Liu LT; Chen QY; Tang LQ; Zhang L; Guo SS; Xie CM; Liu XW; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    Radiology; 2017 Jan; 282(1):171-181. PubMed ID: 27479804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of subjective olfaction ratings in patients with and without olfactory disorders.
    Haxel BR; Bertz-Duffy S; Fruth K; Letzel S; Mann WJ; Muttray A
    J Laryngol Otol; 2012 Jul; 126(7):692-7. PubMed ID: 22588245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Olfactory event-related potentials (OERPs) and trigeminal event-related potentials (TERPs) - a pilot study in Czech participants with normal sense of smell.
    Holy R; Janouskova K; Vasina L; Maute E; Kalfert D; Maminak K; Augste E; Hlozek J; Schulz H; Funda D; Astl J
    J Appl Biomed; 2023 Dec; 21(4):167-173. PubMed ID: 38112455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.